CPRIT Grants: Texas Funding Programs & Rules

The Cancer Prevention and Research Institute of Texas (CPRIT) provides state-funded grants supporting academic research, clinical translation, and prevention interventions. Created through voter-approved constitutional amendments, CPRIT represents a $6 billion public investment in cancer science. In the broader landscape of modern oncology, CPRIT grants form the largest state-level cancer funding program in the United States and the second-largest public cancer research funder globally.

What it is and who runs it

The Cancer Prevention and Research Institute of Texas (CPRIT) is an official state agency of Texas, established by the Texas Legislature under Texas Health and Safety Code Chapter 102. As described on the official page on 2026-11-08, CPRIT is governed by an independent Oversight Committee that guides grant allocations and policy. The institute operates under a legislative mandate to accelerate scientific breakthroughs, strengthen institutional research capabilities across Texas universities and medical centers, and implement the comprehensive Texas Cancer Plan.

CPRIT grant funding operates alongside federal allocations detailed in our overview of cancer research funding and federal awards like NCI funding. Unlike federal grant agencies that fund nationally, CPRIT awards are legally restricted to public and private entities located within the state of Texas. To ensure objectivity and eliminate institutional favoritism, all CPRIT scientific grant applications undergo rigorous peer review conducted exclusively by out-of-state scientific panels composed of distinguished national and international cancer researchers.

Eligibility (summary, with the official source)

Eligibility requirements for CPRIT grants are governed by Texas statutory rules and agency guidelines, as described on the official page on 2026-11-08. Primary eligibility standards include:

Texas Geographic Nexus: Primary applicant organizations must be legally established and actively operating public or private entities in Texas. Eligible entities include universities, health science centers, independent non-profit research institutes, hospitals, and private life science companies. Out-of-state organizations cannot receive direct prime awards, though subcontracts for specialized services are permitted with documented justification.
Principal Investigator Appointment: PIs submitting through academic research mechanisms must hold a full-time or eligible faculty appointment at an authorized Texas institution. Clinical and translational proposals often bridge clinical disciplines, paralleling research divisions discussed in our comparison of oncology vs. hematology.
Recruitment Award Qualifications: For CPRIT Scholar recruitment awards (such as Established Investigators, Rising Stars, or First-Time Faculty), candidate nominees must be recruited from institutions outside Texas to establish their laboratories at Texas institutions.
Matching Funds Requirement: Certain CPRIT grant categories require statutory institutional matching funds. For product development research grants awarded to private companies, recipients must contribute matching private funds (typically 50% non-state match) to validate commercial viability.
Good Standing and Reporting: Institutions and PIs must be fully compliant with all state disclosure rules, ethics requirements, and reporting milestones on active CPRIT awards.

What it funds or requires

As described on the official page on 2026-11-08, CPRIT distributes grant support through formal Requests for Applications (RFAs) organized into three core program tracks:

Academic Research Program: Funds investigator-initiated laboratory, translational, and clinical investigations. Mechanisms include Catalyst Pilot Research Awards (up to $250,000 over 2 years), Individual Investigator Research Awards, Clinical Investigator Awards (up to $1.5 million over 5 years), Core Facility Support Awards (up to $2 million over 5 years), and Research Training Awards (up to $4 million over 5 years).
Prevention Program: Supports community-based public health interventions across Texas, including Cancer Screening and Early Detection grants (up to $1.5 million for new projects; $2.5 million for expansions) and Primary Prevention grants addressing tobacco control, vaccination, and diet. Clinical services must be delivered directly to Texas residents.
Product Development Research: Provides non-dilutive bridge capital to early-stage biotechnology and medical technology companies developing novel oncology therapeutics, medical devices, and diagnostics within Texas.
Research Integrity Governance: Awardees must adhere to strict state conflict-of-interest standards and regulatory approvals (IRB, IACUC). PIs should note that state disclosure obligations complement federal frameworks covered in our guide on NIH financial conflict of interest regulations.

Application or compliance steps

Applying for CPRIT funding involves structured electronic submission through state portals in response to active RFAs:

Select an Active RFA: Review open funding solicitations on the CPRIT funding portal. Solicitations specify scientific priorities, award ceilings, project durations, and evaluation criteria.
Access the Grant Management Platform: Register on CPRIT’s electronic application receipt platform (grants.cprit.texas.gov / cpritgrants.org). PIs must create individual profiles and associate them with their host institution.
Coordinate Institutional Approvals: Establish user links with institutional Authorized Signing Officials (ASO), financial contacts, and compliance officers well ahead of submission deadlines.
Draft the Application Narrative: Structure the research plan according to RFA guidelines, including Background, Significance, Preliminary Data, Research Design, Clinical Relevance to Texas, and a detailed budget breakdown.
Submit Required Attachments: Upload biographical sketches, institutional letters of commitment, facilities descriptions, matching fund certifications, and human/animal subject protection documentation.
Submit Prior to Deadline: Complete institutional validation and submit electronically before the designated deadline. ASOs must complete final electronic certification for the submission to be considered complete.

Researchers serving as project directors should review administrative responsibilities outlined in our guide on what a principal investigator does to ensure successful oversight.

Typical timeline phases (no calendar dates as facts)

CPRIT grant awards follow a multi-tier review cycle that operates on defined seasonal phases rather than fixed calendar dates:

RFA Release and Application Window: Requests for Applications are released publicly several weeks before application receipt portals open. Application submission windows generally remain open for 6 to 10 weeks.
Out-of-State Scientific Peer Review: Over a multi-month period, applications are reviewed by specialized peer-review panels composed exclusively of experts outside Texas. Reviewers evaluate scientific merit, innovation, significance, and feasibility, producing preliminary numerical scores and critiques.
Program Integration Committee Review: Highly scored applications advance to CPRIT’s Program Integration Committee (PIC), which evaluates proposals for strategic alignment with the Texas Cancer Plan and state portfolio balance.
Oversight Committee Final Approval: The Oversight Committee conducts final review and formally votes on funding slates during public quarterly meetings.
Contracting and Award Activation: Following award approval, CPRIT contract administrators execute formal grant contracts with recipient institutions, establishing quarterly progress reporting and financial drawdowns.

Common mistakes

Applicants frequently encounter avoidable compliance obstacles during proposal development. Common errors include:

Non-Texas Prime Applicant: Submitting an application with an out-of-state prime institution, which results in immediate administrative disqualification.
Omitting Relevance to Texas: Failing to articulate the potential impact of the research on cancer burden, patient populations, or life science capabilities within Texas.
Matching Fund Deficiencies: In commercial or training mechanisms requiring co-funding, failing to secure verifiable institutional or private matching commitments prior to contract execution.
Unregistered Institutional Signatories: Waiting until the day of submission to initiate institutional ASO approval, causing missed portal deadlines.
Budget Inflation Beyond RFA Caps: Requesting budgets or project periods that exceed the strict limits published in the specific RFA.

Related programs

CPRIT offers distinct grant mechanisms tailored to basic discovery, infrastructure development, workforce training, and commercial translation. Researchers should evaluate these mechanisms alongside complementary federal and non-profit funding lines:

Program Mechanism	Target Applicants	Maximum Award Amount	Maximum Duration	Primary Strategic Goal
Catalyst Pilot Research Award	Academic faculty across Texas	$250,000	2 years	Generate foundational data for novel, high-risk cancer research projects
Individual Investigator Research Award	Independent Texas faculty	Varies by RFA cycle	3 to 4 years	Support investigator-initiated basic, translational, and clinical cancer studies
Clinical Investigator Award	Mid-career clinician-scientists	$1.5 million	5 years	Provide protected research time and mentoring support in clinical oncology
Core Facility Support Award	Texas research institutions	$2.0 million	5 years	Establish shared laboratory resources and instrumentation for multi-user research
Research Training Award	Institutional training programs	$4.0 million	5 years	Support workforce development for predoctoral, postdoctoral, and clinical fellows
Cancer Screening & Early Detection	Clinical systems and non-profits	$1.5M (new) / $2.5M (expansion)	5 years	Deliver evidence-based cancer screening to underserved populations in Texas
Product Development Grant	Texas life science companies	Varies by RFA (milestone-based)	3 to 5 years	Advance therapeutics, medical devices, and diagnostics through clinical trials

FAQ

Is CPRIT a government agency?

Yes. The Cancer Prevention and Research Institute of Texas (CPRIT) is an official state agency of Texas, created by the Texas Legislature under Texas Health and Safety Code Chapter 102 and governed by an independent Oversight Committee.

How is the Cancer Prevention and Research Institute of Texas (CPRIT) funded?

CPRIT is funded through voter-approved state general obligation bonds. Texas voters approved an initial $3 billion bond commitment in 2007 and passed a constitutional amendment in 2019 authorizing an additional $3 billion, creating a $6 billion, 20-year public investment in cancer research.

How do I apply for funding from CPRIT?

Applicants must apply online in response to formal Requests for Applications (RFAs) through CPRIT’s electronic application receipt platform (grants.cprit.texas.gov / cpritgrants.org). Prime applicants must be public or private entities located in Texas.

Can researchers outside Texas apply for CPRIT grants?

Researchers outside Texas cannot apply directly as prime applicants. However, out-of-state researchers may participate as subaward collaborators or be recruited to a Texas institution through CPRIT Scholar recruitment awards.

Who reviews CPRIT grant applications?

Applications undergo scientific peer review conducted exclusively by out-of-state scientific panels composed of independent experts from leading institutions outside Texas. This ensures zero institutional conflicts of interest within the state.

Sources

Cancer Prevention and Research Institute of Texas (CPRIT): About Us, https://www.cprit.texas.gov/about-us/, read 2026-11-08.
Cancer Prevention and Research Institute of Texas (CPRIT): Funding Opportunities, https://www.cprit.texas.gov/funding-opportunities/, read 2026-11-08.